Currently, there are 606.39M common shares owned by the public and among those 597.84M shares have been available to trade.
The company’s stock has a 5-day price change of -2.17% and -53.29% over the past three months. GERN shares are trading -61.86% year to date (YTD), with the 12-month market performance down to -63.32% lower. It has a 12-month low price of $1.17 and touched a high of $5.34 over the same period. GERN has an average intraday trading volume of 15.36 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -7.38%, -26.31%, and -61.61% respectively.
Institutional ownership of Geron Corp (NASDAQ: GERN) shares accounts for 76.62% of the company’s 606.39M shares outstanding.
It has a market capitalization of $859.83M and a beta (3y monthly) value of 0.81. The earnings-per-share (ttm) stands at -$0.27. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.34% over the week and 9.11% over the month.
Analysts forecast that Geron Corp (GERN) will achieve an EPS of -0.04 for the current quarter, -0.03 for the next quarter and -0.04 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.04 while analysts give the company a high EPS estimate of -0.04. Comparatively, EPS for the current quarter was -0.09 a year ago. Earnings per share for the fiscal year are expected to increase by 60.03%, and 113.37% over the next financial year.
Looking at the support for the GERN, a number of firms have released research notes about the stock. B. Riley Securities stated their Neutral rating for the stock in a research note on February 27, 2025, with the firm’s price target at $3.50-$2. Leerink Partners on their part issued Outperform rating on September 09, 2024.
